Literature DB >> 21506925

The role of eosinophils in non-parasitic infections.

Stefanie N Linch1, Jeffrey A Gold.   

Abstract

Eosinophils are a subset of leukocytes traditionally associated with Th2-related diseases and helminth infections. However, accumulating evidence suggests eosinophils play a more prominent role in the immune response to bacterial and viral pathogens than previously realized. Specifically, eosinophils possess antimicrobial properties against a broad range of pathogens, and release specific and secondary granules as a result of pathogen recognition. Pathogen recognition is accomplished through expression of Toll-like receptors, as well as other surface and intracellular receptors expressed by the eosinophil. Interestingly, specific killing mechanisms employed by each granule protein differ based on pathogen recognition, but ultimately release of eosinophil granules leads to direct killing of many different pathogens. The precise mechanisms of killing by granule proteins and the circumstances in which specific proteins are secreted are only now being determined. Future efforts to understand these mechanisms may lead toward clinical use of granule proteins as antimicrobial agents in humans, in addition to revealing implications regarding the use of eosinophil-depleting therapies for allergic disorders. This review will summarize the literature to date regarding the role of eosinophils in non-parasitic infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506925      PMCID: PMC5962354          DOI: 10.2174/187153011795564188

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  58 in total

Review 1.  Eosinophils function as antigen-presenting cells.

Authors:  Huan-Zhong Shi
Journal:  J Leukoc Biol       Date:  2004-06-24       Impact factor: 4.962

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  The eosinophil.

Authors:  Marc E Rothenberg; Simon P Hogan
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 4.  Eosinophils: biological properties and role in health and disease.

Authors:  Simon P Hogan; Helene F Rosenberg; Redwan Moqbel; Simon Phipps; Paul S Foster; Paige Lacy; A Barry Kay; Marc E Rothenberg
Journal:  Clin Exp Allergy       Date:  2008-04-01       Impact factor: 5.018

5.  Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.

Authors:  B Olszewska-Pazdrak; K Pazdrak; P L Ogra; R P Garofalo
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

6.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

7.  Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups.

Authors:  Lena Svensson; Christine Wennerås
Journal:  Microbes Infect       Date:  2005-03-22       Impact factor: 2.700

8.  Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.

Authors:  Marc Torrent; Susanna Navarro; Mohammed Moussaoui; M Victòria Nogués; Ester Boix
Journal:  Biochemistry       Date:  2008-02-23       Impact factor: 3.162

9.  Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b.

Authors:  Juhan Yoon; Jens U Ponikau; Christopher B Lawrence; Hirohito Kita
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

10.  Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.

Authors:  Hiroyuki Nagase; Shu Okugawa; Yasuo Ota; Masao Yamaguchi; Hideyuki Tomizawa; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Koichi Hirai
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

View more
  3 in total

Review 1.  Eosinophils in infection and intestinal immunity.

Authors:  Simon P Hogan; Amanda Waddell; Patricia C Fulkerson
Journal:  Curr Opin Gastroenterol       Date:  2013-01       Impact factor: 3.287

Review 2.  Novel targeted therapies for eosinophil-associated diseases and allergy.

Authors:  Susanne Radonjic-Hoesli; Peter Valent; Amy D Klion; Michael E Wechsler; Hans-Uwe Simon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-17       Impact factor: 13.820

3.  Eosinophils and Neutrophils-Molecular Differences Revealed by Spontaneous Raman, CARS and Fluorescence Microscopy.

Authors:  Aleksandra Dorosz; Marek Grosicki; Jakub Dybas; Ewelina Matuszyk; Marko Rodewald; Tobias Meyer; Jürgen Popp; Kamilla Malek; Malgorzata Baranska
Journal:  Cells       Date:  2020-09-07       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.